gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Vitrectomy for Diabetic Macular Edema

Meeting Abstract

Search Medline for

  • corresponding author H. Hoerauf - Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Augenheilkunde, Lübeck
  • D. Lühmann - Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Institut für Sozialmedizin, Lübeck

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogDO.03.13

The electronic version of this article is the complete one and can be found online at:

Published: September 22, 2004

© 2004 Hoerauf et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Vitrectomy is gaining popularity among the treatment modalities for diffuse diabetic macular edema (DME). Recent case series and retrospective studies reported promising results.

However, most of the published studies presented very small and heterogenous patient groups as well as differing treatment modalities. Our systematic review of the literature did not find one randomized controlled trial which could proove the effectiveness of vitrectomy for DME. Against this background, we report the results of our own prospective randomized trial that investigated the question whether in patients with DME a posterior vitreous detachment (PVD) alone or with an additional removal of the inner limiting membrane (ILM) is advantageous. The evidence arising from these new data and the results of the published studies are critically discussed.